Consolidated Statement of Stockholders' Deficit (Unaudited) - USD ($)	Series A Preferred Stock [Member] Preferred Stock [Member]	Series C Preferred Stock [Member] Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Series F Preferred Stock Issuable [Member]	Common Stock Issuable [Member]	Subscription Receivable [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022		$ 200	$ 7,544	$ 24,427,009			$ (261,059)	$ (25,320,424)	$ (1,146,730)
Balance, shares at Dec. 31, 2022		2,000,000	75,437,604
Reclassification of convertible debt				(247,142)					(247,142)
Exercise of warrants						6,000			6,000
Net loss								(380,952)	(380,952)
Balance at Mar. 31, 2023		$ 200	$ 7,544	24,179,867		6,000	(261,059)	(25,701,376)	(1,768,824)
Balance, shares at Mar. 31, 2023		2,000,000	75,437,604
Balance at Dec. 31, 2023		$ 200	$ 8,662	24,853,028			(261,059)	(26,736,403)	(2,135,572)
Balance, shares at Dec. 31, 2023		2,000,000	86,623,596
Net loss								(3,688,470)	(3,688,470)
Stock issuance for services			$ 956	306,029					306,985
Stock issuance for services, shares			9,555,462
Conversion of convertible debt						421,312			421,312
Settlement of derivative liabilities				306,904					306,904
Acquistion of Emergent Health Corp.					4,722,776				4,722,776
Balance at Mar. 31, 2024		$ 200	$ 9,618	$ 25,465,961	$ 4,722,776	$ 421,312	$ (261,059)	$ (30,424,873)	$ (66,065)
Balance, shares at Mar. 31, 2024		2,000,000	96,179,058